Ticker Launch
Sign inTry it free

SPAC · Merger completed

Social Capital Suvretta Holdings Corp. III

Business combination with ProKidney LP

Social Capital Suvretta Holdings Corp. III is a blank-check company (SPAC) that raised $220M in its initial public offering on Jul 1, 2021. It completed its business combination with ProKidney LP on Jul 11, 2022; the combined company is ProKidney Corp. (PROK). Morgan Stanley led the IPO. Wachtell Lipton advised the SPAC and Ropes & Gray advised the underwriters on the IPO.

ProKidney LP is developing REACT (Renal Autologous Cell Therapy), its lead product candidate. REACT is a patented, disease-modifying autologous cellular therapy intended to slow and stabilize chronic kidney disease and, in some cases, improve kidney function.

Status
Merger completed
IPO date
Jul 1, 2021
IPO size
$220M
Target
ProKidney LP
Announced
Jan 18, 2022
Closed
Jul 11, 2022
Combined company
ProKidney Corp. (PROK)
IPO underwriters
Morgan Stanley
SPAC counsel (IPO)
Wachtell Lipton and Maples and Calder
Underwriters' counsel (IPO)
Ropes & Gray

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2022